Variables | na | Cases/controls | Arg vs. Gly | Arg/Arg vs. Gly/Gly | Gly/Arg+Arg/Arg vs. Gly/Gly | Arg/Arg vs. Gly/Gly+ Gly/Arg | ||||
---|---|---|---|---|---|---|---|---|---|---|
 |  |  | OR (95% CI) | Pb | OR (95% CI) | Pb | OR (95% CI) | Pb | OR (95% CI) | Pb |
Total | 5 | 2618/2305 | 1.17 (1.07-1.29) | 0.37 | 1.39 (0.97-1.99) | 0.08 | 1.21 (1.08-1.36) | 0.79 | 1.32 (0.90-1.94)c | 0.03 |
Caucasian | 3 | 1935/1787 | 1.21 (1.00-1.47) | 0.09 | 1.40 (0.80-2.45)c | 0.04 | 1.23 (1.08-1.40) | 0.39 | 1.26 (0.72-2.19)c | 0.04 |
African | 2 | 191/174 | 1.15 (0.73-1.82) | 0.95 | 2.17 (0.20-23.14) | 0.17 | 1.11 (0.66-1.86) | 0.62 | 2.21 (0.18-26.83) | 0.15 |
Asian | 1 | 492/344 | 1.24 (1.02-1.51) | - | 1.52 (1.05-2.22) | - | 1.15 (0.86-1.54) | - | 1.53 (1.10-2.14) | - |
Tumor stage | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Localized | Â | Â | 1.00 (reference) | Â | 1.00 (reference) | Â | 1.00 (reference) | Â | 1.00 (reference) | Â |
Advanced | Â | Â | 1.18 (0.96-1.44) | 0.75 | 1.33 (0.91-1.96) | 0.89 | 1.01 (0.93-1.10) | 0.44 | 1.34 (1.03-1.74) | 0.61 |